These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7818565)

  • 1. Inhibition of complement activation by intravenous immunoglobulins.
    Qi M; Schifferli JA
    Arthritis Rheum; 1995 Jan; 38(1):146. PubMed ID: 7818565
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition.
    Basta M
    Mol Immunol; 2008 Oct; 45(16):4073-9. PubMed ID: 18706699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
    Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL
    J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation.
    Lutz HU; Späth PJ
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):207-12. PubMed ID: 16391395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of complement in immunohematology.
    Giles CM
    Transfusion; 1989; 29(9):803-11. PubMed ID: 2686108
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular organization and function of the complement system.
    Müller-Eberhard HJ
    Annu Rev Biochem; 1988; 57():321-47. PubMed ID: 3052276
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and control of the complement system.
    Reid KB
    Essays Biochem; 1986; 22():27-68. PubMed ID: 3549286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins.
    Appeltshauser L; Weishaupt A; Sommer C; Doppler K
    Exp Neurol; 2017 Jan; 287(Pt 1):84-90. PubMed ID: 27746185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin drugs do not affect serum complement activation in vitro.
    Lappegård KT; Hvassing T; Mollnes TE
    Scand J Immunol; 2004; 60(1-2):178-83. PubMed ID: 15238087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P; Leibowitch J
    Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiology and pathophysiology of complement: progress and trends.
    Morgan BP
    Crit Rev Clin Lab Sci; 1995; 32(3):265-98. PubMed ID: 7495498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement and complement regulatory proteins in glomerulonephritis.
    Quigg RJ
    Springer Semin Immunopathol; 2003 May; 24(4):395-410. PubMed ID: 12778335
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement. Historical perspectives and some current issues.
    Mayer MM
    Complement; 1984; 1(1):2-26. PubMed ID: 6100484
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
    [No Abstract]   [Full Text] [Related]  

  • 18. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 19. [The complement system as a mediator of acute inflammation].
    Müller-Peddinghaus R
    Dtsch Tierarztl Wochenschr; 1983 Sep; 90(9):374-7. PubMed ID: 6354683
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.